PROARRHYTHMIC EFFECTS OF THE CLASS-III AGENT ALMOKALANT - IMPORTANCE OF INFUSION RATE, QT DISPERSION, AND EARLY AFTERDEPOLARIZATIONS

被引:165
作者
CARLSSON, L
ABRAHAMSSON, C
ANDERSSON, B
DUKER, G
SCHILLERLINHARDT, G
机构
[1] Astra Hässle AB, Preclinical Research and Development, Cardiovascular Pharmacology
关键词
D O I
10.1093/cvr/27.12.2186
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The aim was to study factors contributing to torsade de pointes in the acquired long QT syndrome. Methods: Anaesthetised rabbits or cats were given a continuous infusion of methoxamine and the class III agent almokalant (at a rate of 5 or 25 nmol.kg(-1).min(-1), respectively) and the effects on incidence of torsade de pointes and QT dispersion were examined. Effects of almokalant on action potentials recorded from Purkinje fibres and ventricular cells of rabbits and cats were also studied. Results: ''High rate'' infusion of almokalant prolonged the QT(c) interval [from 162(SEM 6.2) ms to 211(5.3) ms, p<0.001] and initiated torsade de pointes in 9/10 rabbits after a dose of 391(116.3) nmol.kg(-1). During ''low rate'' infusion, 1/8 rabbits developed torsade de pointes (p = 0.0029) despite infusion of 900 nmol.kg(-1) almokalant and QT(c) prolongation from 162(3.6) ms to 230(12.6) ms (p<0.01). In eight separate rabbits given the high rate infusion of almokalant, seven developed torsade de pointes and the QT(c) dispersion increased from 15(1.7) ms to 32(5.6) ms (p<0.05). In six rabbits given the low rate infusion, none developed torsade de pointes (p = 0.0023), and the QT(c) dispersion was unaltered. In six cats, high rate infusion induced a QT interval lengthening from 241(6.0) ms to 349(8.0) ms (p<0.001), but in only one cat was torsade de pointes initiated and preceded by a marked increase in QT dispersion (from 22 ms to 78 ms). In vitro, almokalant caused a marked lengthening of the action potential duration and early afterdepolarisations in Purkinje fibres but not in ventricular muscle cells of the rabbit. In the cat, however, almokalant induced a homogeneous prolongation of the action potential duration in both cell types, and early afterdepolarisations were never observed. Conclusions: The rate of infusion of repolarisation delaying agents may influence the dispersion of repolarisation and play a decisive role in the initiation of torsade de pointes.
引用
收藏
页码:2186 / 2193
页数:8
相关论文
共 38 条
[31]   WHEN IS QT PROLONGATION ANTIARRHYTHMIC AND WHEN IS IT PROARRHYTHMIC [J].
SINGH, BN .
AMERICAN JOURNAL OF CARDIOLOGY, 1989, 63 (12) :867-869
[32]   ELECTROPHYSIOLOGIC SUBSTRATE OF TORSADE DE POINTES - DISPERSION OF REPOLARIZATION OR EARLY AFTERDEPOLARIZATIONS [J].
SURAWICZ, B .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 14 (01) :172-184
[33]   PLASMA-CONCENTRATIONS OF QUINIDINE, ITS MAJOR METABOLITES, AND DIHYDROQUINIDINE IN PATIENTS WITH TORSADES-DE-POINTES [J].
THOMPSON, KA ;
MURRAY, JJ ;
BLAIR, IA ;
WOOSLEY, RL ;
RODEN, DM .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (06) :636-642
[34]   AN IMPROVED METHOD TO CORRECT THE QT INTERVAL OF THE ELECTROCARDIOGRAM FOR CHANGES IN HEART-RATE [J].
VANDEWATER, A ;
VERHEYEN, J ;
XHONNEUX, R ;
RENEMAN, RS .
JOURNAL OF PHARMACOLOGICAL METHODS, 1989, 22 (03) :207-217
[35]   EXPERIMENTAL-MODELS OF TORSADES-DE-POINTES [J].
WEISSENBURGER, J ;
DAVY, JM ;
CHEZALVIEL, F .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1993, 7 (01) :29-38
[36]   DIFFERENTIAL-EFFECTS OF THE NEW CLASS-III ANTIARRHYTHMIC AGENTS ALMOKALANT, E-4031 AND D-SOTALOL, AND OF QUINIDINE, ON DELAYED RECTIFIER CURRENTS IN GUINEA-PIG VENTRICULAR MYOCYTES [J].
WETTWER, E ;
GRUNDKE, M ;
RAVENS, U .
CARDIOVASCULAR RESEARCH, 1992, 26 (11) :1145-1152
[37]   ELECTROPHARMACOLOGIC EFFECTS AND PHARMACOKINETICS OF ALMOKALANT, A NEW CLASS-III ANTIARRHYTHMIC, IN PATIENTS WITH HEALED OR HEALING MYOCARDIAL INFARCTS AND COMPLEX VENTRICULAR ARRHYTHMIAS [J].
WIESFELD, ACP ;
CRIJNS, HJGM ;
TOBE, TJM ;
ALMGREN, O ;
BERGSTRAND, RH ;
ABERG, J ;
HAAKSMA, J ;
LIE, KI .
AMERICAN JOURNAL OF CARDIOLOGY, 1992, 70 (11) :990-996
[38]   PHARMACOLOGY OF THE CLASS-III ANTIARRHYTHMIC AGENT SEMATILIDE IN PATIENTS WITH ARRHYTHMIAS [J].
WONG, W ;
PAVLOU, HN ;
BIRGERSDOTTER, UM ;
HILLEMAN, DE ;
MOHIUDDIN, SM ;
RODEN, DM .
AMERICAN JOURNAL OF CARDIOLOGY, 1992, 69 (03) :206-212